Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06233110
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-01-22
Brief Title:
Ruxolitinib Plus Fostamatinib for Steroid Refractory CGvHD
Sponsor:
Organization:
Duke University